Author(s):
Gayathri M K, Pavithra K, Vishnu T, Ragavendhiran M, S Meena
Email(s):
meenus1493@gmail.com
DOI:
10.52711/0975-4377.2026.00049 
Address:
Gayathri M K1, Pavithra K2, Vishnu T3, Ragavendhiran M4, S Meena5*
1Department of Pharmaceutics, JKKN College of Pharmacy, Komarapalayam, 638183, Tamil Nadu, India. ORCID ID: 0009-0009-3253-1547.
2Department of Pharmaceutics, JKKN College of Pharmacy, Komarapalayam, 638183, Tamil Nadu, India. ORCID ID: 0009-0005-5891-1936.
3Department of Pharmaceutics, JKKN College of Pharmacy, Komarapalayam, 638183, Tamil Nadu, India. ORCID ID: 0009-0006-8388-4690.
4Department of Pharmaceutics, JKKN College of Pharmacy, Komarapalayam, 638183, Tamil Nadu, India. ORCID ID: 0009-0005-4079-1681.
5*Assistant Professor, Department of Pharmaceutics, JKKN College of Pharmacy, Komarapalayam, 638183, Tamil Nadu, India. ORCID ID: 0009-0008-1078-8707.
*Corresponding Author
Published In:
Volume - 18,
Issue - 4,
Year - 2026
ABSTRACT:
Background: Aspirin has a short biological half-life and may cause gastrointestinal irritation, creating a rationale for sustained-release delivery. This study evaluated crude Musa sp. banana peel powder (BPP), an abundant polysaccharide-rich agricultural by-product, as a natural matrix former and compared its performance with hydroxypropyl methylcellulose (HPMC). Methods: Aspirin matrix tablets were prepared by dry granulation using 60 mg BPP (F1), 90 mg BPP (F2), or HPMC as the reference polymer. BPP swelling, powder flow, tablet weight variation, friability, hardness, thickness, 12-hour in-vitro drug release, and release kinetics were evaluated. Results: BPP exhibited a swelling index of 156.91%, confirming appreciable hydration capacity. All batches showed workable flow and acceptable physical characteristics, although HPMC produced the strongest tablets and lowest friability. Increasing BPP from 60 to 90 mg improved hardness from 4.40 to 5.97 kg/cm² and reduced friability from 0.83% to 0.54%. F1 released 82.7% aspirin within 3 hours, demonstrating inadequate retardation. In contrast, F2 released 44.3%, 69.8%, and 97.6% at 3, 6, and 12hours, respectively, closely approaching the HPMC profile of 42.8%, 67.7%, and 98.4%. Mean dissolution times were 2.28, 5.40, and 5.76 hours for F1, F2, and HPMC, respectively. F2 and HPMC fitted the Korsmeyer–Peppas model (R²=0.9962 and 0.9984) and showed anomalous non-Fickian transport. Conclusion: At 90 mg, crude BPP formed a functional hydrophilic matrix capable of sustaining aspirin release for 12 hours, with performance approaching HPMC. Its pharmaceutical use requires excipient standardization, compatibility, stability, salicylic-acid, content-uniformity, batch-reproducibility, and in-vivo studies before it can be considered a viable alternative.
Cite this article:
Gayathri M K, Pavithra K, Vishnu T, Ragavendhiran M, S Meena. Formulation and Evaluation of Aspirin Sustained Release Tablets: A Comparative Study of Musa sp. (Banana) Peel Powder Versus Semi-Synthetic Polymer. Research Journal of Pharmaceutical Dosage Forms and Technology. 2026; 18(4):350-8. doi: 10.52711/0975-4377.2026.00049
Cite(Electronic):
Gayathri M K, Pavithra K, Vishnu T, Ragavendhiran M, S Meena. Formulation and Evaluation of Aspirin Sustained Release Tablets: A Comparative Study of Musa sp. (Banana) Peel Powder Versus Semi-Synthetic Polymer. Research Journal of Pharmaceutical Dosage Forms and Technology. 2026; 18(4):350-8. doi: 10.52711/0975-4377.2026.00049 Available on: https://www.rjpdft.com/AbstractView.aspx?PID=2026-18-4-11
REFERENCES:
1. Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 1985; 10(2): 164-177. doi:10.2165/00003088-198510020-00004
2. Laine L. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?. Aliment Pharmacol Ther. 2006, 24(6): 897-908. doi:10.1111/j.1365-2036.2006. 03077.x
3. Lanas A, Wu P, Medin J, Mills EJ. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol. 2011; 9(9): 762-768.e6. doi: 10.1016/j.cgh.2011.05.020
4. Ford JD. Design and Evaluation of Hydroxypropyl Methylcellulose Matrix Tablets for Oral Controlled Release: A Historical Perspective. Published online January 1, 2014: 17-51. doi: https://doi.org/10.1007/978-1-4939-1519-4_2
5. Senarat S, Phaechamud T, Pornsawad P, Chaiya P. Effervescence-modulated drug release from HPMC matrix tablets: Mechanistic insight and numerical estimation of water and ibuprofen diffusivity. Journal of Drug Delivery Science and Technology. 2025,113:107285. doi: https://doi.org/10.1016/j.jddst.2025.107285
6. Blynskaya, E. V., Tishkov, S. V., Vinogradov, V. P., Alekseev, K. V., Marakhova, A. I., and Vetcher, A. A. Polymeric Excipients in the Technology of Floating Drug Delivery Systems. Pharmaceutics. 2022; 14(12): 2779. https://doi.org/10.3390/pharmaceutics14122779
7. Zhang, Y., Wang, Y., Lu, Y., Quan, H., Wang, Y., Song, S., and Guo, H. Advanced oral drug delivery systems for gastrointestinal targeted delivery: the design principles and foundations. Journal of Nanobiotechnology. 2025; 23(1): 400. https://doi.org/10.1186/s12951-025-03479-8
8. Pereira MAF, Cesca K, Poletto P, de Oliveira D. New perspectives for banana peel polysaccharides and their conversion to oligosaccharides. Food Res Int. 2021; 149: 110706. doi: 10.1016/j.foodres.2021.110706
9. Mishra, S., Prabhakar, B., Kharkar, P. S., and Pethe, A. M. Banana Peel Waste: An Emerging Cellulosic Material to Extract Nanocrystalline Cellulose. ACS Omega. 2022; 8(1): 1140–1145. https://doi.org/10.1021/acsomega.2c06571
10. Vemula SK, Daravath B, Gummadi SB, Repka M. Formulation and Development of Flurbiprofen Colon-Specific Eudragit Coated Matrix Tablets: Use of a Novel Crude Banana Peel Powder as a Time-Dependent Polymer. AAPS PharmSciTech. 2023; 24(7): 189. Published 2023 Sep 19. doi:10.1208/s12249-023-02646-0
11. Ghori MU, Ginting G, Smith AM, Conway BR. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices. International Journal of Pharmaceutics. 2014; 465(1-2): 405-412. doi: https://doi.org/10.1016/j.ijpharm.2014.02.028
12. Conti S, Maggi L, Segale L, et al. Matrices containing NaCMC and HPMC: 2. Swelling and release mechanism study. International Journal of Pharmaceutics. 2007; 333(1): 143-151. doi: https://doi.org/10.1016/j.ijpharm.2006.11.067
13. Vemula SK, Daravath B, Gummadi SB, Repka M. Formulation and Development of Flurbiprofen Colon-Specific Eudragit Coated Matrix Tablets: Use of a Novel Crude Banana Peel Powder as a Time-Dependent Polymer. AAPS PharmSciTech. 2023; 24(7): 189. Published 2023 Sep 19. doi:10.1208/s12249-023-02646-0
14. Ofori-Kwakye K, Mfoafo KA, Kipo SL, Kuntworbe N, Boakye-Gyasi ME. Development and evaluation of natural gum-based extended-release matrix tablets of two model drugs of different water solubilities by direct compression. Saudi Pharmaceutical Journal. 2016; 24(1): 82-91. doi: https://doi.org/10.1016/j.jsps.2015.03.005
15. Ghimire M, Hodges LA, Band J, et al. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets. Journal of Controlled Release. 2010; 147(1): 70-75. doi: https://doi.org/10.1016/j.jconrel.2010.06.015
16. Kavanagh N, Corrigan OI. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices—influence of agitation rate and dissolution medium composition. International Journal of Pharmaceutics. 2004; 279(1-2): 141-152. doi: https://doi.org/10.1016/j.ijpharm.2004.04.016